Previous 10 | Next 10 |
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For November
PRA Health Sciences, Inc. (PRAH) Q3 2020 Earnings Conference Call November 5, 2020 09:00 AM ET Company Participants Christopher Gaenzle - Executive Vice President, Chief Administrative Officer and General Counsel Colin Shannon - Chairman, President and Chief Executive Officer Michael Bonello ...
The following slide deck was published by PRA Health Sciences, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: PRA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. PRA Health Sciences Inc (NASDAQ: PRAH) Q3 2020 Earnings Call Nov 5, 2020 , 9:00 a.m. ET Operator Continue reading For further details see: PRA Health Sciences Inc (PRAH) Q3 2020 Earnings Call Transcript
PRA Health Sciences (PRAH): Q3 Non-GAAP EPS of $1.30 beats by $0.16; GAAP EPS of $1.41 beats by $0.73.Revenue of $796.3M (+2.0% Y/Y) beats by $27.16M.FY20 guidance: Revenue of $3.120B-$3.150B vs consensus of $3.10B, GAAP net income per diluted share of $3.23-$3.35 and non-GAAP net income per ...
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenue Net new business of $986.0 million; Net book-to-bill of 1.35 including reimbursement revenue $796.3 million of total revenue; representing growth of...
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The Company will also host a conference call on Thursday, November 5, 2020 at 9:00 a.m. (ET)...
With the new contract, PRA will assist Biomedical Advanced Research and Development Authority (BARDA) in the development of medical countermeasures for public health RALEIGH, N.C., Oct. 06, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. ...
I last covered PRA in May 2019 - the stock is up 14% since then, which was at the top end of my forecast at the time. Market selloffs aside, PRA's share price has hovered between $100-$110 mark for nearly 2 years - tough operating conditions due to the pandemic may be holding it back....
PRA Health Sciences ( PRAH -0.2% ) announced a new strategic relationship with Deep Lens, Inc., to accelerate patient access and recruitment for oncology clinical trials. More news on: PRA Health Sciences, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...